Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Franceschini

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Urology Open Science|April 9, 2024
Intraoperative Performance of DaVinci Versus Hugo RAS During Radical Prostatectomy: Focus on Timing, Malfunctioning, Complications, and User Satisfaction in 100 Consecutive Cases (the COMPAR-P Trial)Alessandro Antonelli, Alessandro Veccia, Sarah Malandra, et al.
Discover Oncology|December 18, 2024
HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patientsGiovanna Talarico, Andrea Franceschini, Alessandro Raveane, et al.
Cancers|February 13, 2026
Prostate Cancer Index Density, the Ratio of Percentage of Biopsy-Positive Cores to Prostate Volume, and Predicted Lethal Disease in the EAU Intermediate Prognostic Risk Class: Analysis and Implications in 651 Consecutive Patients Treated with Robot-Assisted Radical Prostatectomy at a Tertiary Referral CentreAntonio Benito Porcaro, Maria Angela Cerruto, Alberto Bianchi, et al.
Nucleic Acids Research|October 30, 2014
STRING v10: protein-protein interaction networks, integrated over the tree of lifeDamian Szklarczyk, Andrea Franceschini, Stefan Wyder, et al.
Viruses|July 27, 2022
Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral EffectsAbhilash Kannan, Maarit Suomalainen, Romain Volle, et al.
JAMA Network Open|July 8, 2026
Germline Multigene Panel Testing in Women With Invasive Lobular CancerGiovanni Corso, Elena Marino, Francesca Fava, et al.
Urologia|May 23, 2024
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experienceAntonio Benito Porcaro, Sonia Costantino, Claudio Brancelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2014
Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screensAndrea Franceschini, Roger Meier, Alain Casanova, et al.
Minerva Urology and Nephrology|October 23, 2025
First prospective comparison between Versius and DaVinci Xi for robotic radical prostatectomy: focus on operative room setup, surgical timing, troubleshooting, and surgeon satisfaction (COMPAR-P Trial)Alessandro Antonelli, Alessandro Veccia, Sarah Malandra, et al.
Asian Journal of Andrology|July 30, 2024
Briganti's 2012 nomogram is an independent predictor of prostate cancer progression in EAU intermediate-risk class: results from 527 patients treated with robotic surgeryAntonio Benito Porcaro, Francesca Montanaro, Alberto Baielli, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Urology Open Science|April 9, 2024
Intraoperative Performance of DaVinci Versus Hugo RAS During Radical Prostatectomy: Focus on Timing, Malfunctioning, Complications, and User Satisfaction in 100 Consecutive Cases (the COMPAR-P Trial)Alessandro Antonelli, Alessandro Veccia, Sarah Malandra, et al.
Discover Oncology|December 18, 2024
HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patientsGiovanna Talarico, Andrea Franceschini, Alessandro Raveane, et al.
Cancers|February 13, 2026
Prostate Cancer Index Density, the Ratio of Percentage of Biopsy-Positive Cores to Prostate Volume, and Predicted Lethal Disease in the EAU Intermediate Prognostic Risk Class: Analysis and Implications in 651 Consecutive Patients Treated with Robot-Assisted Radical Prostatectomy at a Tertiary Referral CentreAntonio Benito Porcaro, Maria Angela Cerruto, Alberto Bianchi, et al.
Nucleic Acids Research|October 30, 2014
STRING v10: protein-protein interaction networks, integrated over the tree of lifeDamian Szklarczyk, Andrea Franceschini, Stefan Wyder, et al.
Viruses|July 27, 2022
Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral EffectsAbhilash Kannan, Maarit Suomalainen, Romain Volle, et al.
JAMA Network Open|July 8, 2026
Germline Multigene Panel Testing in Women With Invasive Lobular CancerGiovanni Corso, Elena Marino, Francesca Fava, et al.
Urologia|May 23, 2024
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experienceAntonio Benito Porcaro, Sonia Costantino, Claudio Brancelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2014
Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screensAndrea Franceschini, Roger Meier, Alain Casanova, et al.
Minerva Urology and Nephrology|October 23, 2025
First prospective comparison between Versius and DaVinci Xi for robotic radical prostatectomy: focus on operative room setup, surgical timing, troubleshooting, and surgeon satisfaction (COMPAR-P Trial)Alessandro Antonelli, Alessandro Veccia, Sarah Malandra, et al.
Asian Journal of Andrology|July 30, 2024
Briganti's 2012 nomogram is an independent predictor of prostate cancer progression in EAU intermediate-risk class: results from 527 patients treated with robotic surgeryAntonio Benito Porcaro, Francesca Montanaro, Alberto Baielli, et al.
Pageof 3